These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Efficiency of cefamandole in the prophylaxis and the treatment of infections of the biliary tract (author's transl)]. Blairon J; Paulet P; Yourassowski E; Limbosch JM Acta Gastroenterol Belg; 1979; 42(9-10):415-26. PubMed ID: 122041 [No Abstract] [Full Text] [Related]
5. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)]. de Vega JC; Pais JR; del Tánago AG Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431 [TBL] [Abstract][Full Text] [Related]
6. A clinical and bacteriologic evaluation of cefamandole therapy in serious skin and skin structure infections. Glanges E; Crenshaw CA; Webber CE Surg Gynecol Obstet; 1980 Apr; 150(4):502-6. PubMed ID: 7361234 [TBL] [Abstract][Full Text] [Related]
7. [Cefamandole: in vitro and in vivo activity]. Martinetto P; Valtz A; Cavallo GP; Angeretti A G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842 [TBL] [Abstract][Full Text] [Related]
8. Cefamandole: pharmacokinetics and therapeutic evaluation in urology. Zinati AH; Naber KG Arzneimittelforschung; 1980; 30(5):839-42. PubMed ID: 7190432 [TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with cefamandole in the field of obstetrics and gynecology (author's transl)]. Yamada F Jpn J Antibiot; 1980 Apr; 33(4):427-8. PubMed ID: 6997531 [TBL] [Abstract][Full Text] [Related]
10. Cefonicid sodium (Monocid). Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400 [No Abstract] [Full Text] [Related]
11. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate]. Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410 [TBL] [Abstract][Full Text] [Related]
12. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin. Fraser DG Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032 [No Abstract] [Full Text] [Related]
13. [Cefamandole as prophylactic A.B. in abdominal surgery. Comparative study of cefamandole versus clindamycin/tobramycin (author's transl)]. Iarchy J Acta Chir Belg; 1980; 79(5):321-6. PubMed ID: 7223262 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of bile duct infections. VIII. Studies on biliary excretion of cefamandole (author's transl)]. Tanimura H; Takenaka M; Hikasa Y; Hashino H; Rai F; Kataoka S; Sato T Jpn J Antibiot; 1979 Oct; 32(10):1049-55. PubMed ID: 513287 [No Abstract] [Full Text] [Related]
15. [Pharmacokinetic studies on the availability of cephamandole in bone and joint infections]. Wittmann DH; Schassan HH; Freitag F Ther Ggw; 1980 Dec; 119(12):1422-35. PubMed ID: 7466689 [No Abstract] [Full Text] [Related]
16. [Clinical evaluation of cefamandole in pediatric surgery (author's transl)]. Hashimoto T; Hayashi S; Narita H; Tsuruga N; Yura J Jpn J Antibiot; 1979 Oct; 32(10):1044-8. PubMed ID: 513286 [No Abstract] [Full Text] [Related]
17. Pre-incisional intraparietal injection of cephamandole: a new approach to wound infection prophylaxis. Armstrong CP; Taylor TV; Reeves DS Br J Surg; 1982 Aug; 69(8):459-60. PubMed ID: 7104633 [TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens. Azanza JR; Honorato J; Rubio A; Cuena R Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597 [No Abstract] [Full Text] [Related]
19. Activity of cephamandole against some gram-negative bacilli and staphylococci. Dzierzanowska D; Jakubicz P; Niedźwiecka M; Borowski J Arch Immunol Ther Exp (Warsz); 1980; 28(3):389-91. PubMed ID: 6969585 [TBL] [Abstract][Full Text] [Related]